Sherwin-Williams Other Non-Current Liabilities increased by 0.6% to $2.59B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.7%, from $2.52B to $2.59B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 13.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.38B | $1.46B | $1.42B | $1.45B | $1.54B | $1.52B | $1.61B | $1.69B | $1.75B | $1.81B | $1.91B | $2.02B | $2.11B | $2.16B | $2.31B | $2.52B | $2.65B | $2.63B | $2.58B | $2.59B |
| QoQ Change | — | +5.6% | -2.4% | +2.1% | +6.3% | -1.3% | +5.5% | +5.2% | +3.4% | +3.7% | +5.3% | +5.7% | +4.5% | +2.4% | +7.0% | +9.2% | +5.2% | -0.9% | -2.0% | +0.6% |
| YoY Change | — | — | — | — | +11.8% | +4.6% | +13.1% | +16.5% | +13.3% | +19.0% | +18.8% | +19.3% | +20.6% | +19.1% | +21.0% | +25.1% | +25.9% | +21.9% | +11.5% | +2.7% |